Altered fibrin clot properties in patients with premature peripheral artery disease

被引:28
|
作者
Okraska-Bylica, Agnieszka [1 ]
Wilkosz, Tadeusz [1 ]
Slowik, Lidia [2 ]
Bazanek, Marta [1 ]
Konieczynska, Malgorzata [1 ]
Undas, Anetta [3 ]
机构
[1] Krakowski Szpital Specjalistyczny Jana Pawla II, PL-31202 Krakow, Poland
[2] Uniwersytet Jagiellonski, Coll Med, Inst Kardiol, Krakow, Poland
[3] Uniwersytet Jagiellonski, Coll Med, Poradnia Chorob Naczyn, Krakow, Poland
来源
POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE | 2012年 / 122卷 / 12期
关键词
ankle brachial index; D-dimer; fibrin clot; peripheral artery disease; NUTRITION EXAMINATION SURVEY; ANKLE-BRACHIAL INDEX; NATIONAL-HEALTH; RISK-FACTORS; INFLAMMATORY MARKERS; HEMOSTATIC FACTORS; VASCULAR-DISEASE; HYPOFIBRINOLYSIS; ATHEROSCLEROSIS; SUSCEPTIBILITY;
D O I
10.20452/pamw.1535
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
INTRODUCTION It has been shown that formation of denser and poorly lysable fibrin clots is observed in elderly patients with peripheral artery disease (PAD). OBJECTIVES The aim of the study was to test the hypothesis that premature PAD is associated with more prothrombotic fibrin clot phenotype. PATIENTS AND METHODS Ex-vivo plasma fibrin clot permeability, turbidity, and susceptibility to lysis were evaluated in 31 premature PAD patients (median ankle brachial index [ABI], 0.75; interquartile range, 0.5-0.8) aged 55 or less and 32 PAD patients (ABI, 0.66; 0.56-0.76) aged over 55 years. Subjects without PAD matched for age and sex (n = 40) served as controls. RESULTS Premature PAD patients were characterized by 32% lower clot permeability (K-s) (P < 0.001), 7% longer clot lysis time (t(50%)) (P = 0.004), and 31% higher maximum D-dimer levels released from fibrin clots (D-D-max) (P < 0.001) compared with controls. These differences remained significant after adjustment for risk factors and medications. None of the fibrin clot parameters differed between premature and older PAD patients. There were correlations between fibrin clot parameters and CRP in premature PAD patients and with ABI in older PAD patients. In a multiple regression model, premature PAD and ABI were independent predictors of K-s, and premature PAD and plasma fibrinogen of the maximum absorbance of a fibrin gel. CONCLUSIONS Plasma fibrin clots show similarly abnormal prothrombotic phenotype in premature and older PAD patients. However, different factors influence fibrin clot parameters in these patient groups. Premature PAD was an independent predictor of clot permeability and maximum absorbance of a fibrin gel.
引用
收藏
页码:608 / 615
页数:8
相关论文
共 50 条
  • [1] Altered plasma fibrin clot properties and fibrinolysis in patients with multiple myeloma
    Undas, Anetta
    Zubkiewicz-Usnarska, Lidia
    Helbig, Grzegorz
    Woszczyk, Dariusz
    Kozinska, Justyna
    Dmoszynska, Anna
    Podolak-Dawidziak, Maria
    Kuliczkowski, Kazimierz
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2014, 44 (06) : 557 - 566
  • [2] Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis
    Kwasny-Krochin, Beata
    Gluszko, Piotr
    Undas, Anetta
    THROMBOSIS RESEARCH, 2010, 126 (01) : E11 - E16
  • [3] Premature atherosclerotic peripheral artery disease: An underrecognized and undertreated disorder with a rising global prevalence
    Mehta, Anurag
    Dhindsa, Devinder S.
    Hooda, Ananya
    Nayak, Aditi
    Massad, Chris S.
    Rao, Birju
    Makue, Leyla Fowe
    Rajani, Ravi R.
    Alabi, Olamide
    Quyyumi, Arshed A.
    Escobar, Guillermo A.
    Wells, Bryan J.
    Sperling, Laurence S.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2021, 31 (06) : 351 - 358
  • [4] Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease Beneficial effects of simvastatin treatment
    Undas, Anetta
    Kaczmarek, Przemyslaw
    Sladek, Krzysztof
    Stepien, Ewa
    Skucha, Wojciech
    Rzeszutko, Marcin
    Gorkiewicz-Kot, Izabela
    Tracz, Wieslawa
    THROMBOSIS AND HAEMOSTASIS, 2009, 102 (06) : 1176 - 1182
  • [5] Altered plasma fibrin clot properties in essential thrombocythemia
    Malecki, Rafal
    Gacka, Malgorzata
    Kuliszkiewicz-Janus, Malgorzata
    Jakobsche-Policht, Urszula
    Kwiatkowski, Jacek
    Adamiec, Rajmund
    Undas, Anetta
    PLATELETS, 2016, 27 (02) : 110 - 116
  • [6] The Burden of Peripheral Artery Disease and the Role of Antiplatelet Therapy
    Aronow, Herbert
    Hiatt, William R.
    POSTGRADUATE MEDICINE, 2009, 121 (04) : 123 - 135
  • [7] The association of lipoprotein(a) and apolipoprotein(a) phenotypes with peripheral artery disease
    Tmoyan, N. A.
    Ezhov, M., V
    Afanasieva, O., I
    Klesareva, E. A.
    Razova, O. A.
    Kukharchuk, V. V.
    Pokrovsky, S. N.
    TERAPEVTICHESKII ARKHIV, 2018, 90 (09) : 31 - 36
  • [8] Type 2 diabetes as a modifier of fibrin clot properties in patients with coronary artery disease
    Maciej Bochenek
    Jaroslaw Zalewski
    Jerzy Sadowski
    Anetta Undas
    Journal of Thrombosis and Thrombolysis, 2013, 35 : 264 - 270
  • [9] The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease
    Neergaard-Petersen, Sos
    Hvas, Anne-Mette
    Kristensen, Steen D.
    Grove, Erik L.
    Larsen, Sanne B.
    Phoenix, Fladia
    Kurdee, Zeyad
    Grant, Peter J.
    Ajjan, Ramzi A.
    THROMBOSIS AND HAEMOSTASIS, 2014, 112 (06) : 1142 - 1150
  • [10] Fibrin Clot Properties in Atherosclerotic Vascular Disease: From Pathophysiology to Clinical Outcomes
    Zabczyk, Michal
    Natorska, Joanna
    Undas, Anetta
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (13)